Intended Use

Imbio IQ-UIP is a computer-aided software indicated for use in passively notifying specialists associated with interstitial lung disease (ILD) centers of radiological findings suggestive of radiological usual interstitial pneumonia (UIP) in non-contrast, chest CT scans of adults.

Technology

The device uses an artificial intelligence algorithm to analyze chest CT images and identify positive findings suggestive of UIP. It provides results on a separate worklist application running in parallel to the standard radiological interpretation workflow, without altering the original images. The model was developed using anonymized, multi-center retrospective chest CT data and validated via ground-truthing by expert radiologists.

Performance

Software validation included integration, regression, algorithm validation, design verification, and standalone performance assessment. The device demonstrated an AUC ROC of 96.6%, sensitivity of 90.2%, and specificity of 91.5% on 804 patient images with a prevalence of 24% for UIP pattern. Ground truth was established by five experienced board-certified radiologists.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    8/20/2024

    4 months
  • 2

    FDA Approval

    12/19/2024

Other devices from Imbio, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.